Aortic stenosis epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 26: Line 26:
{{Reflist|2}}
{{Reflist|2}}


[[Category:DiseaseState]]
[[Category:Cardiac surgery]]
[[Category:Signs and symptoms]]
[[Category:Surgery]]
[[Category:Physical Examination]]
[[Category:Overview complete]]
[[Category:Template complete]]
[[Category:Disease state]]
[[Category:Valvular heart disease]]
[[Category:Valvular heart disease]]
[[Category:Cardiology]]
[[Category:Cardiology]]
Line 43: Line 45:


{{WH}}
{{WH}}
{{WS}}
{{WS}}

Revision as of 17:08, 7 October 2011

Aortic Stenosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Aortic Stenosis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Cardiac Stress Test

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography

Cardiac Catheterization

Aortic Valve Area

Aortic Valve Area Calculation

Treatment

General Approach

Medical Therapy

Surgery

Percutaneous Aortic Balloon Valvotomy (PABV) or Aortic Valvuloplasty

Transcatheter Aortic Valve Replacement (TAVR)

TAVR vs SAVR
Critical Pathway
Patient Selection
Imaging
Evaluation
Valve Types
TAVR Procedure
Post TAVR management
AHA/ACC Guideline Recommendations

Follow Up

Prevention

Precautions and Prophylaxis

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Aortic stenosis epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Aortic stenosis epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Aortic stenosis epidemiology and demographics

CDC on Aortic stenosis epidemiology and demographics

Aortic stenosis epidemiology and demographics in the news

Blogs on Aortic stenosis epidemiology and demographics

Directions to Hospitals Treating Aortic stenosis epidemiology and demographics

Risk calculators and risk factors for Aortic stenosis epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editors-In-Chief: Claudia P. Hochberg, M.D. [2], Abdul-Rahman Arabi, M.D. [3], Keri Shafer, M.D. [4], Mohammed A. Sbeih, M.D. [5]; Assistant Editor-In-Chief: Kristin Feeney, B.S. [6]

Overview

Aortic stenosis is a major health problem primarily affecting older adults. As North American and European populations continue to live longer, aortic stenosis has major implications on the overall personal health and economic burden. The abnormalities of aortic valve morphology and function represent the most common cardiac-valve lesion particularly in elderly. The etiology of aortic stenosis is degenerative-calcific in the majority of patients.

Prevalence

Aortic stenosis is a common problem found predominantly in middle age to older adults. Less than 1% of all live births exhibit symptoms of severe aortic stenosis. Prevalence increases with age. Approximately 2% of people over the age of 65, 3% of people over age 75, and 4% of people over age 85 have the disorder. In North America and Europe, a linear relationship exists between an aging population and an increase in aortic stenosis.

the aortic valve sclerosis (aortic valve thickening and calcification without pressure gradient) seem to affect about one fourth of adults over 65 years of age, while the aortic valve stenosis is present in 2–9% of general population over 65 years of age; an increased prevalence of both sclerosis and stenosis with aging (48% and 4% in those over 85 years) is observed. Furthermore, the number of the aortic valve procedures performed over the last 10 years is increasing if we consider the aortic valve replacement alone or combined with myocardial revascularization; mitral valve surgery seems to be constant in the same period [1].

In the Euro Heart Survey on Valvular Heart Disease, aortic valve stenosis was the most common valve abnormality (33,9% and 46,6% in the overall group and surgical subgroup, respectively). The etiology of aortic stenosis was degenerative-calcific in the majority of patients (81,9%), while it was rheumatic in 11.2%, congenital in 5.6% and post-endocarditis in the remaining 1,3%. Among the 512 aortic stenosis patients who underwent valve replacement, 54,3% were elderly (more than 70 years), 80% had a preserved left ventricular systolic function (left ventricular ejection fraction >60%) and 85% had symptoms of heart failure (NYHA class II-IV) [2].

In the Cardiovascular Health Study, the Doppler echocardiographic examination performed in 5621 subjects older than 65 year without prevalent cardiovascular disease at entry identified an aortic sclerosis (valve thickening and iperreflectivity) in 29% of overall population and an aortic stenosis (valve abnormalities and instantaneous pressure gradient >25 mmHg) in 2% [3].

As a disease, aortic stenosis has a high rate of morbidity and mortality resulting in a large personal and economic burden on affected populations. Without medical intervention, aortic stenosis can be a major health problem.

Incidence

The incidence of aortic stenosis is correlated to the age of the patient, primarily affecting older adults. Every year, approximately 29% of people older than 65 years and 37% of people older than 75 years become symptomatic of aortic stenosis.

Sources

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1550260/

References

  1. Passik CS, Ackermann DM, Pluth JR, Edwards WD (1987). "Temporal changes in the causes of aortic stenosis: a surgical pathologic study of 646 cases". Mayo Clin Proc. 62 (2): 119–23. PMID 3807436.
  2. Iung B, Baron G, Butchart EG, Delahaye F, Gohlke-Bärwolf C, Levang OW; et al. (2003). "A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease". Eur Heart J. 24 (13): 1231–43. PMID 12831818.
  3. Stewart BF, Siscovick D, Lind BK, Gardin JM, Gottdiener JS, Smith VE; et al. (1997). "Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study". J Am Coll Cardiol. 29 (3): 630–4. PMID 9060903.


Template:WH Template:WS